Details of Drug

Drug General Information (ID: D1353)
Drug Name	Propafenone
Drug Type	Small molecule
Drug Synonymous	Propafenona; Propafenonum; Rythmol; Propafenon Hexal; Propafenon hexal (TN); Propafenona [INN-Spanish]; Propafenone (INN); Propafenone [INN:BAN]; Propafenone-HCl; Propafenonum [INN-Latin]; Rythmol SR (TN); Rytmonorm (TN); 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone; 1-(2-(2-Hydroxy-3-propylaminopropoxy)phenyl)-3-phenylpropan-1-one; 1-[2-(2-Hydroxy-3-(propylamino)propoxy)phenyl]-3-phenyl-1-propanone hydrochloride; 1-[2-(2-Hydroxy-3-[propylamino]-propoxy)phenyl]-3-phenyl-1-propanone; 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one Click to Show/Hide
Disease Class	BC71: Ventricular tachyarrhythmia
Therapeutic Class	Antiarrhythmic Agents
Structure
Structure	3D Structure		2D Structure
Formula	C21H27NO3
InChI	1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3
InChIKey	JWHAUXFOSRPERK-UHFFFAOYSA-N
Canonical SMILES	CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
External Link
	Pubchem ID	4932
	CAS Number	54063-53-5
	CHEBI ID	63619
	TTD ID	D0J2KV
	VARIDT ID	DR00634

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects BM003 Complex formation BM010 Transporter inhibition BM016 Altered formation of CYP450 enzymes BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM026 Increased metabolism (Unspecific) BM038 Additive CNS depression effects BM042 Additive hypotensive effects BM044 Additive myelosuppressive effects BM049 Increased risk of atrioventricular block BM051 Increased risk of bradycardia BM076 Increased risk of prolong QT interval BM078 Increased risk of rapid heart rate BM081 Increased risk of ventricular arrhythmias
Relation Graph

Full list of drugs interacting with Propafenone
Affected gastrointestinal absorption
	Complex formation					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0381		Colesevelam	C31H67Cl3N4O	160051	Moderate		Inter Info	[7], [303]
Affected cellular transport
	Transporter inhibition					Drug Num: 21
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0171		Berotralstat	C30H26F4N6O	137528262	Major		Inter Info	[109]
D0176		Betrixaban	C23H22ClN5O3	10275777	Major		Inter Info	[110], [111], [112]
D0380		Colchicine	C22H25NO6	6167	Major		Inter Info	[115], [116], [117]
D1232		Pazopanib	C21H23N7O2S	10113978	Major		Inter Info	[8], [9], [141], [142]
D1688		Venetoclax	C45H50ClN7O7S	49846579	Major		Inter Info	[8], [9], [158]
D0429		Daunorubicin	C27H29NO10	30323	Moderate		Inter Info	[305], [306], [307], [308]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Moderate		Inter Info	[305], [307], [308]
D0788		Idarubicin	C26H27NO9	42890	Moderate		Inter Info	[305], [306], [307], [308]
D0038		Aliskiren	C30H53N3O6	5493444	Moderate		Inter Info	[7], [9], [377], [378]
D0096		Apixaban	C25H25N5O4	10182969	Moderate		Inter Info	[9], [379], [310]
D0182		Binimetinib	C17H15BrF2N4O3	10288191	Moderate		Inter Info	[8], [9], [388]
D0629		Everolimus	C53H83NO14	6442177	Moderate		Inter Info	[399], [310]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Moderate		Inter Info	[8], [9], [408]
D0963		Lusutrombopag	C29H32Cl2N2O5S	49843517	Moderate		Inter Info	[42]
D1407		Rimegepant	C28H28F2N6O3	51049968	Moderate		Inter Info	[422]
D1409		Ripretinib	C24H21BrFN5O2	71584930	Moderate		Inter Info	[8], [423]
D1532		Talazoparib	C19H14F2N6O	135565082	Moderate		Inter Info	[9], [429]
D1608		Tolvaptan	C26H25ClN2O3	216237	Moderate		Inter Info	[432]
D1663		Ubrogepant	C29H26F3N5O3	68748835	Moderate		Inter Info	[433]
D0425		Darolutamide	C19H19ClN6O2	67171867	Minor		Inter Info	[482]
D0658		Fidaxomicin	C52H74Cl2O18	10034073	Minor		Inter Info	[483]
Affected intra/extra-hepatic metabolism
	Altered formation of CYP450 enzymes					Drug Num: 18
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0023		Adalimumab	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D0032		Alefacept	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D0085		Anakinra	C20H23N5O7S2	146171046	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D0614		Etanercept	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D0802		Infliximab	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D0246		Canakinumab	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D0304		Certolizumab pegol	NA	NA	Moderate		Inter Info	[222], [224], [229]
D0564		Emapalumab	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D0736		Golimumab	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D0747		Guselkumab	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D0875		Ixekizumab	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D1403		Rilonacept	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D1447		Sarilumab	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D1448		Satralizumab	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D1454		Secukinumab	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D1467		Siltuximab	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D1599		Tocilizumab	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
D1671		Ustekinumab	NA	NA	Moderate		Inter Info	[9], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232]
	CYP450 enzyme inhibition					Drug Num: 90
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0375		Cobicistat	C40H53N7O5S2	25151504	Major		Inter Info	[17]
D0559		Eliglustat	C23H36N2O4	23652731	Major		Inter Info	[120], [121]
D1388		Relugolix	C29H27F2N7O5S	10348973	Major		Inter Info	[143]
D1444		Saquinavir	C38H50N6O5	441243	Major		Inter Info	[146], [147]
D1415		Ritonavir	C37H48N6O5S2	392622	Major		Inter Info	[8], [9], [162], [163], [164]
D1533		Tamoxifen	C26H29NO	2733526	Major		Inter Info	[165], [166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [121], [191], [192], [193], [194], [195], [196], [197], [198]
D1596		Tizanidine	C9H8ClN5S	5487	Major		Inter Info	[203], [204], [205], [206], [207], [208], [209], [157]
D0043		Alosetron	C17H18N4O	2099	Moderate		Inter Info	[240]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[241], [242], [145]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[241], [242], [145]
D0080		Amprenavir	C25H35N3O6S	65016	Moderate		Inter Info	[5], [243]
D0087		Anisindione	C16H12O3	2197	Moderate		Inter Info	[244], [4], [245], [246]
D0100		Aprepitant	C23H21F7N4O3	135413536	Moderate		Inter Info	[5], [243]
D0220		Bupropion	C13H18ClNO	444	Moderate		Inter Info	[248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258]
D0267		Carvedilol	C24H26N2O4	2585	Moderate		Inter Info	[259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [4], [278], [279], [280], [281], [282], [283]
D0298		Celecoxib	C17H14F3N3O2S	2662	Moderate		Inter Info	[284]
D0308		Cevimeline	C10H17NOS	83898	Moderate		Inter Info	[285]
D0313		Chloramphenicol	C11H12Cl2N2O5	5959	Moderate		Inter Info	[5], [243]
D0337		Cimetidine	C10H16N6S	2756	Moderate		Inter Info	[286]
D0338		Cinacalcet	C22H22F3N	156419	Moderate		Inter Info	[8], [163], [287]
D0356		Clobazam	C16H13ClN2O2	2789	Moderate		Inter Info	[288], [289]
D0367		Clotrimazole	C22H17ClN2	2812	Moderate		Inter Info	[5], [243]
D0379		Codeine	C18H21NO3	5284371	Moderate		Inter Info	[291], [292], [293], [294], [295], [296], [121], [297], [298], [299], [300], [301], [302]
D0386		Conivaptan	C32H26N4O2	151171	Moderate		Inter Info	[5], [243]
D0424		Darifenacin	C28H30N2O2	444031	Moderate		Inter Info	[304]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[241], [242], [145]
D0466		Dextromethorphan	C18H25NO	5360696	Moderate		Inter Info	[8], [9], [309], [139], [310], [311]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[5], [243]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[241], [242], [145]
D0526		Doxepin (topical)	C19H21NO	667477	Moderate		Inter Info	[241], [242], [145]
D0539		Duloxetine	C18H19NOS	60835	Moderate		Inter Info	[312], [313]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[315], [316], [317], [318], [319], [320]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[315], [316], [317], [318], [319], [320]
D0707		Galantamine	C17H21NO3	9651	Moderate		Inter Info	[321]
D0793		Imatinib	C29H31N7O	5291	Moderate		Inter Info	[323]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[241], [242], [145]
D0799		Indinavir	C36H47N5O4	5362440	Moderate		Inter Info	[5], [243]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Moderate		Inter Info	[5], [243]
D0916		Levobupivacaine	C18H28N2O	92253	Moderate		Inter Info	[9], [357]
D1049		Metoprolol	C15H25NO3	4171	Moderate		Inter Info	[259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [4], [278], [279], [280], [281], [282], [283]
D1117		Nefazodone	C25H32ClN5O2	4449	Moderate		Inter Info	[5], [243]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[241], [242], [145]
D1229		Paroxetine	C19H20FNO3	43815	Moderate		Inter Info	[315], [316], [317], [318], [319], [320]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[374]
D0007		Abiraterone	C24H31NO	132971	Moderate		Inter Info	[311]
D0010		Acebutolol	C18H28N2O4	1978	Moderate		Inter Info	[259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [4], [278], [279], [280], [281], [282], [283]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[8], [9], [380], [381], [382], [383], [384], [385]
D0157		Bendamustine	C16H21Cl2N3O2	65628	Moderate		Inter Info	[387]
D0192		Boceprevir	C27H45N5O5	10324367	Moderate		Inter Info	[5], [243]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[241], [242], [145]
D0409		Dacomitinib	C24H25ClFN5O2	11511120	Moderate		Inter Info	[390]
D0413		Dalfopristin	C34H50N4O9S	6323289	Moderate		Inter Info	[5], [391], [243]
D0426		Darunavir	C27H37N3O7S	213039	Moderate		Inter Info	[5], [243]
D0545		Echinacea	NA	NA	Moderate		Inter Info	[394]
D0638		Fedratinib	C27H36N6O3S	16722836	Moderate		Inter Info	[5], [243]
D0655		Fesoterodine	C26H37NO3	6918558	Moderate		Inter Info	[400]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Moderate		Inter Info	[5], [243]
D0693		Fosaprepitant	C23H22F7N4O6P	135413538	Moderate		Inter Info	[5], [243]
D0724		Givosiran	C78H139N11O30	119058042	Moderate		Inter Info	[403]
D0732		Glycerol phenylbutyrate	C33H38O6	10482134	Moderate		Inter Info	[9], [405]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[5], [243]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Moderate		Inter Info	[5], [243]
D0906		Letermovir	C29H28F4N4O4	45138674	Moderate		Inter Info	[5], [243]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Moderate		Inter Info	[5], [243]
D0952		Lorcaserin	C11H14ClN	11658860	Moderate		Inter Info	[410]
D1074		Mirabegron	C21H24N4O2S	9865528	Moderate		Inter Info	[411]
D1114		Nebivolol	C22H25F2NO4	71301	Moderate		Inter Info	[259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [4], [278], [279], [280], [281], [282], [283]
D1127		Netupitant	C30H32F6N4O	6451149	Moderate		Inter Info	[5], [391], [243]
D1244		Penbutolol	C18H29NO2	37464	Moderate		Inter Info	[259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [4], [278], [279], [280], [281], [282], [283]
D1385		Rasagiline	C12H13N	3052776	Moderate		Inter Info	[8], [9], [420]
D1422		Roflumilast	C17H14Cl2F2N2O3	449193	Moderate		Inter Info	[9], [424], [425]
D1423		Rolapitant	C25H26F6N2O2	10311306	Moderate		Inter Info	[121]
D1471		Simeprevir	C38H47N5O7S2	24873435	Moderate		Inter Info	[427]
D1536		Tasimelteon	C15H19NO2	10220503	Moderate		Inter Info	[430]
D1541		Telaprevir	C36H53N7O6	3010818	Moderate		Inter Info	[5], [243]
D1653		Troleandomycin	C41H67NO15	202225	Moderate		Inter Info	[5], [243]
D1357		Propranolol	C16H21NO2	4946	Moderate		Inter Info	[259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [4], [278], [279], [280], [281], [282], [283]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[241], [242], [145]
D1378		Ramelteon	C16H21NO2	208902	Moderate		Inter Info	[445]
D1427		Ropinirole	C16H24N2O	5095	Moderate		Inter Info	[454], [455]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[315], [316], [317], [318], [319], [320]
D1534		Tamsulosin	C20H28N2O5S	129211	Moderate		Inter Info	[457], [458], [459], [121]
D1553		Terbinafine	C21H25N	1549008	Moderate		Inter Info	[463], [464], [465], [466]
D1585		Timolol	C13H24N4O3S	33624	Moderate		Inter Info	[259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [4], [278], [279], [280], [281], [282], [283]
D1586		Timolol (ophthalmic)	C13H24N4O3S	33624	Moderate		Inter Info	[468], [469], [470]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[241], [242], [145]
D1711		Warfarin	C19H16O4	54678486	Moderate		Inter Info	[244], [4], [245], [246]
D1728		Zolmitriptan	C16H21N3O2	60857	Moderate		Inter Info	[9], [305]
D0516		Donepezil	C24H29NO3	3152	Minor		Inter Info	[451], [121], [477], [478]
D1607		Tolterodine	C22H31NO	443879	Minor		Inter Info	[488], [489], [121]
	CYP450 enzyme induction					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[398]
D1167		Olaparib	C24H23FN4O3	23725625	Moderate		Inter Info	[8], [9], [42]
D1401		Rifapentine	C47H64N4O12	135403821	Moderate		Inter Info	[421], [245]
D1400		Rifampicin	C43H58N4O12	135398735	Moderate		Inter Info	[448], [449], [450]
	Increased metabolism (Unspecific)					Drug Num: 10
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0224		Butabarbital	C10H16N2O3	2479	Minor		Inter Info	[476]
D0225		Butalbital	C11H16N2O3	2481	Minor		Inter Info	[476]
D1024		Methohexital	C14H18N2O3	9034	Minor		Inter Info	[476]
D1040		Methylphenobarbital	C13H14N2O3	8271	Minor		Inter Info	[476]
D1248		Pentobarbital	C11H18N2O3	4737	Minor		Inter Info	[476]
D1265		Phenobarbital	C12H12N2O3	4763	Minor		Inter Info	[476]
D1340		Primidone	C12H14N2O2	4909	Minor		Inter Info	[476]
D0071		Amobarbital	C11H18N2O3	2164	Minor		Inter Info	[476]
D1453		Secobarbital	C12H18N2O3	5193	Minor		Inter Info	[476]
D1573		Thiopental	C11H18N2O2S	3000715	Minor		Inter Info	[476]
Pharmacodynamic additive effects
	Additive CNS depression effects					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0452		Deutetrabenazine	C19H27NO3	73437646	Moderate		Inter Info	[393]
D1673		Valbenazine	C24H38N2O4	24795069	Moderate		Inter Info	[434]
	Additive hypotensive effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0942		Lofexidine	C11H12Cl2N2O	30668	Moderate		Inter Info	[7], [8], [9], [409], [42]
	Additive myelosuppressive effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0370		Clozapine	C18H19ClN4	135398737	Major		Inter Info	[44], [45]
	Increased risk of atrioventricular block					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0116		Atazanavir	C38H52N6O7	148192	Major		Inter Info	[16], [17]
D0992		Mefloquine	C17H16F6N2O	4046	Moderate		Inter Info	[9], [127], [367]
D0885		Lacosamide	C13H18N2O3	219078	Moderate		Inter Info	[407]
	Increased risk of bradycardia					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1163		Octreotide	C49H66N10O10S2	448601	Moderate		Inter Info	[369], [370]
D0031		Alectinib	C30H34N4O2	49806720	Moderate		Inter Info	[375], [376]
D0891		Lanreotide	C54H69N11O10S2	71349	Moderate		Inter Info	[369], [370]
D1600		Tofacitinib	C16H20N6O	9926791	Moderate		Inter Info	[8], [367]
	Increased risk of prolong QT interval					Drug Num: 159
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[7], [8], [9], [10]
D0200		Bretylium	C11H17BrN+	2431	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D0320		Chloroquine	C18H26ClN3	2719	Major		Inter Info	[18], [9], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36]
D0342		Cisapride	C23H29ClFN3O4	6917698	Major		Inter Info	[7], [8], [9], [37], [38], [39]
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[7], [8], [9], [40], [41], [42], [43]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[46]
D0514		Dolasetron	C19H20N2O3	3033818	Major		Inter Info	[47]
D0535		Droperidol	C22H22FN3O2	3168	Major		Inter Info	[7], [8], [9], [48], [49], [42]
D0554		Efavirenz	C14H9ClF3NO2	64139	Major		Inter Info	[50]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[7], [51], [8], [9], [52], [53], [42]
D0712		Gatifloxacin	C19H22FN3O4	5379	Major		Inter Info	[54], [55], [56], [7], [8], [9], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76]
D0740		Grepafloxacin	C19H22FN3O3	72474	Major		Inter Info	[55], [7], [8], [9], [77], [78], [79]
D0750		Haloperidol	C21H23ClFNO2	3559	Major		Inter Info	[7], [8], [9], [80], [81], [82], [83], [84], [85], [42]
D0787		Ibutilide	C20H36N2O3S	60753	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D1010		Mesoridazine	C21H26N2OS2	4078	Major		Inter Info	[7], [8], [9], [86], [42]
D1017		Methadone	C21H27NO	4095	Major		Inter Info	[7], [8], [9], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [42]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[7], [8], [9], [97]
D1092		Moxifloxacin	C21H24FN3O4	152946	Major		Inter Info	[54], [55], [56], [7], [8], [9], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76]
D1223		Papaverine	C20H21NO4	4680	Major		Inter Info	[98], [99], [100], [101], [102], [103], [104], [105]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[9], [48], [106], [42]
D1343		Procainamide	C13H21N3O	4913	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D0067		Amisulpride	C17H27N3O4S	2159	Major		Inter Info	[107]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Major		Inter Info	[108]
D0170		Bepridil	C24H34N2O	2351	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[9], [113]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[7], [8], [9], [114]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[118]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[7], [8], [9], [119]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Major		Inter Info	[123], [7], [8], [9], [124], [125], [126], [127], [128]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Major		Inter Info	[18], [9], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[7], [8], [9], [129], [42]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[132]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[133]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[9], [134], [42]
D0960		Lumefantrine	C30H32Cl3NO	6437380	Major		Inter Info	[8], [9], [135]
D0965		Macimorelin	C26H30N6O3	9804938	Major		Inter Info	[136]
D1136		Nilotinib	C28H22F3N7O	644241	Major		Inter Info	[7], [8], [9], [45]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[137]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[139]
D1230		Pasireotide	C58H66N10O9	9941444	Major		Inter Info	[7], [8], [9], [140]
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[7], [8], [9], [48], [61], [144], [145], [42]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[9], [148]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Major		Inter Info	[55], [7], [8], [9], [150], [151], [59], [61], [63], [152], [64], [65], [153], [67], [68], [69], [70], [154], [74], [79], [155]
D1681		Vandetanib	C22H24BrFN4O2	3081361	Major		Inter Info	[7], [8], [9], [156]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Major		Inter Info	[7], [8], [9], [157]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[1], [159], [2], [3], [160], [4], [5], [161], [6]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D1574		Thioridazine	C21H26N2S2	5452	Major		Inter Info	[7], [8], [9], [199], [48], [200], [201], [202], [42]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[7], [8], [9], [210]
D1726		Ziprasidone	C21H21ClN4OS	60854	Major		Inter Info	[7], [8], [9], [48], [211], [42]
D0003		Abarelix	C72H95ClN14O14	16131215	Moderate		Inter Info	[9], [212], [213], [214], [215], [216], [217], [218]
D0036		Alfuzosin	C19H27N5O4	2092	Moderate		Inter Info	[7], [8], [9], [239], [42]
D0097		Apomorphine	C17H17NO2	6005	Moderate		Inter Info	[7], [8], [9], [247], [42]
D0115		Astemizole	C28H31FN4O	2247	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0119		Atomoxetine	C17H21NO	54841	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0139		Azithromycin	C38H72N2O12	447043	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0180		Bicalutamide	C18H14F4N2O4S	2375	Moderate		Inter Info	[9], [212], [213], [214], [215], [216], [217], [218]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0336		Cilostazol	C20H27N5O2	2754	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0358		Clofazimine	C27H22Cl2N4	2794	Moderate		Inter Info	[290]
D0467		Dextropropoxyphene	C22H29NO2	10100	Moderate		Inter Info	[61], [145], [42]
D0528		Doxorubicin	C27H29NO11	31703	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0529		Doxorubicin (liposomal)	C27H29NO11	31703	Moderate		Inter Info	[61], [145], [42]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0597		Erythromycin	C37H67NO13	12560	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[8], [9], [314]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0682		Flutamide	C11H11F3N2O3	3397	Moderate		Inter Info	[9], [212], [213], [214], [215], [216], [217], [218]
D0694		Foscarnet	CH3O5P	3415	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Moderate		Inter Info	[55], [63], [64], [69], [322]
D0737		Goserelin	C59H84N18O14	5311128	Moderate		Inter Info	[9], [212], [213], [214], [215], [216], [217], [218]
D0738		Granisetron	C18H24N4O	5284566	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0751		Halothane	C2HBrClF3	3562	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0908		Leuprolide	C59H84N16O12	657181	Moderate		Inter Info	[9], [212], [213], [214], [215], [216], [217], [218]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[55], [7], [8], [9], [59], [60], [61], [358], [359], [64], [65], [360], [66], [361], [67], [68], [69], [70], [362], [363], [364], [74], [79]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0947		Loperamide	C29H33ClN2O2	3955	Moderate		Inter Info	[365], [366]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1075		Mirtazapine	C17H19N3	4205	Moderate		Inter Info	[368]
D1137		Nilutamide	C12H10F3N3O4	4493	Moderate		Inter Info	[9], [212], [213], [214], [215], [216], [217], [218]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[55], [7], [8], [9], [59], [60], [61], [358], [359], [64], [65], [360], [66], [361], [67], [68], [69], [70], [362], [363], [364], [74], [79]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[55], [7], [8], [9], [59], [60], [61], [358], [359], [64], [65], [360], [66], [361], [67], [68], [69], [70], [362], [363], [364], [74], [79]
D1166		Olanzapine	C17H20N4S	135398745	Moderate		Inter Info	[8], [9], [371]
D1181		Ondansetron	C18H19N3O	4595	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1210		Oxytocin	C43H66N12O12S2	439302	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1216		Palonosetron	C19H24N2O	6337614	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1246		Pentamidine	C19H24N4O2	4735	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1254		Perflutren	C3F8	6432	Moderate		Inter Info	[372], [373]
D1257		Perphenazine	C21H26ClN3OS	4748	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1339		Primaquine	C15H21N3O	4908	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1351		Promazine	C17H20N2S	4926	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0037		Alimemazine	C18H22N2S	5574	Moderate		Inter Info	[61], [145], [42]
D0095		Apalutamide	C21H15F4N5O2S	24872560	Moderate		Inter Info	[9], [212], [213], [214], [215], [216], [217], [218]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[7], [8], [9], [386], [42]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Moderate		Inter Info	[9], [389]
D0349		Clarithromycin	C38H69NO13	84029	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[392]
D0437		Degarelix	C82H103ClN18O16	16136245	Moderate		Inter Info	[9], [212], [213], [214], [215], [216], [217], [218]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[395]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[8], [9], [396]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[9], [212], [213], [214], [215], [216], [217], [218]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[7], [8], [9], [397]
D0632		Ezogabine	C16H18FN3O2	121892	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0664		Flecainide	C17H20F6N2O3	3356	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0700		Fostemsavir	C25H26N7O8P	11319217	Moderate		Inter Info	[401]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[402]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[404]
D0758		Histrelin	C66H86N18O12	25077993	Moderate		Inter Info	[9], [212], [213], [214], [215], [216], [217], [218]
D0806		Inotuzumab ozogamicin	NA	NA	Moderate		Inter Info	[9], [406]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Moderate		Inter Info	[9]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[61], [145], [42]
D1026		Methotrimeprazine	C19H24N2OS	72287	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1169		Oliceridine	C22H30N2O2S	66553195	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1189		Osilodrostat	C13H10FN3	44139752	Moderate		Inter Info	[9], [412]
D1215		Paliperidone	C23H27FN4O3	115237	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1290		Pimavanserin	C25H34FN3O2	10071196	Moderate		Inter Info	[415]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1315		Posaconazole	C37H42F2N8O4	468595	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1342		Probucol	C31H48O2S2	4912	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1368		Quetiapine	C21H25N3O2S	5002	Moderate		Inter Info	[7], [8], [9], [48], [416], [417], [418], [419], [42]
D1404		Rilpivirine	C22H18N6	6451164	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1424		Romidepsin	C24H36N4O6S2	5352062	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1463		Sevoflurane	C4H3F7O	5206	Moderate		Inter Info	[7], [8], [9], [426]
D1491		Solifenacin	C23H26N2O2	154059	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[7], [8], [9], [428]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1560		Tetrabenazine	C19H27NO3	6018	Moderate		Inter Info	[7], [8], [9], [431], [42]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1356		Propofol	C12H18O	4943	Moderate		Inter Info	[435], [436], [437], [438], [439], [440], [441], [442], [443], [444]
D1383		Ranolazine	C24H33N3O4	56959	Moderate		Inter Info	[446], [447]
D1413		Risperidone	C23H27FN4O2	5073	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Moderate		Inter Info	[7], [8], [9], [456]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1544		Telithromycin	C43H65N5O10	3002190	Moderate		Inter Info	[7], [8], [9], [460], [461], [462]
D1555		Terfenadine	C32H41NO2	5405	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1616		Tramadol	C16H25NO2	33741	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[471], [472], [380], [473], [474], [475], [42]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1638		Triflupromazine	C18H19F3N2S	5568	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1682		Vardenafil	C23H32N6O4S	135400189	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1706		Voriconazole	C16H14F3N5O	71616	Moderate		Inter Info	[7], [8], [9], [48], [61], [145], [42]
D1051		Metronidazole	C6H9N3O3	4173	Minor		Inter Info	[8], [479], [480], [481]
D1516		Sulfamethoxazole	C10H11N3O3S	5329	Minor		Inter Info	[7], [8], [9], [484], [485], [486], [487]
	Increased risk of rapid heart rate					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0101		Arbutamine	C18H23NO4	60789	Major		Inter Info	[11], [12], [13]
	Increased risk of ventricular arrhythmias					Drug Num: 36
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0107		Arsenic trioxide	As2O3	14888	Major		Inter Info	[14], [15]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[7], [8], [9], [122], [43]
D0868		Ivabradine	C27H36N2O5	132999	Major		Inter Info	[9], [130], [131]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[138]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[8], [149]
D0025		Adenosine	C10H13N5O4	60961	Moderate		Inter Info	[7], [233], [8], [9], [234], [235], [236], [37], [237], [238]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336], [337], [338], [339], [340], [341], [342], [343], [344], [345], [346], [347], [348], [349], [350], [351], [352], [353]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[337], [347], [350]
D0888		Lactulose	C12H22O11	11333	Moderate		Inter Info	[7], [8], [9], [354], [355], [356]
D1185		Orciprenaline	C11H17NO3	4086	Moderate		Inter Info	[337], [347], [350]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336], [337], [338], [339], [340], [341], [342], [343], [344], [345], [346], [347], [348], [349], [350], [351], [352], [353]
D0184		Bisacodyl	C22H19NO4	2391	Moderate		Inter Info	[7], [8], [9], [354], [355], [356]
D0269		Castor oil	C57H104O9	14030006	Moderate		Inter Info	[7], [8], [9], [354], [355], [356]
D0701		Frangula purshiana bark	NA	NA	Moderate		Inter Info	[8], [9], [356]
D0731		Glycerin	C3H8O3	753	Moderate		Inter Info	[7], [8], [9], [354], [355], [356]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336], [337], [338], [339], [340], [341], [342], [343], [344], [345], [346], [347], [348], [349], [350], [351], [352], [353]
D0887		Lactitol	C12H24O11	157355	Moderate		Inter Info	[7], [8], [9], [354], [355], [356]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[337], [347], [350]
D0970		Magnesium citrate	C12H10Mg3O14	6099959	Moderate		Inter Info	[7], [8], [9], [354], [355], [356]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[7], [8], [9], [354], [355], [356]
D1069		Mineral oil	NA	NA	Moderate		Inter Info	[7], [8], [9], [354], [355], [356]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336], [337], [338], [339], [340], [341], [342], [343], [344], [345], [346], [347], [348], [349], [350], [351], [352], [353]
D1266		Phenolphthalein	C20H14O4	4764	Moderate		Inter Info	[7], [8], [9], [354], [355], [356]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[9], [413], [414]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336], [337], [338], [339], [340], [341], [342], [343], [344], [345], [346], [347], [348], [349], [350], [351], [352], [353]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[9], [413], [414]
D1309		Polyethylene glycol (3350)	C2H6O2	174	Moderate		Inter Info	[8], [9], [356]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[9], [413], [414]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[337], [347], [350]
D1414		Ritodrine	C17H21NO3	33572	Moderate		Inter Info	[324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336], [337], [338], [339], [340], [341], [342], [343], [344], [345], [346], [347], [348], [349], [350], [351], [352], [353]
D1418		Rivastigmine	C14H22N2O2	77991	Moderate		Inter Info	[7], [8], [9], [451], [452], [453]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[337], [347], [350]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336], [337], [338], [339], [340], [341], [342], [343], [344], [345], [346], [347], [348], [349], [350], [351], [352], [353]
D1525		Tacrine	C13H14N2	1935	Moderate		Inter Info	[7], [8], [9], [451], [452], [453]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336], [337], [338], [339], [340], [341], [342], [343], [344], [345], [346], [347], [348], [349], [350], [351], [352], [353]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[8], [9], [467]

References
1	Buss J, Neuss H, Bilgin Y, Schlepper M "Malignant ventricular tachyarrhythmias in association with propafenone treatment." Eur Heart J 6 (1985): 424-8. [PMID: 4043097]
2	Hii JT, Wyse DG, Gillis AM, et al "Propafenone-induced torsade de pointes: cross-reactivity with quinidine." Pacing Clin Electrophysiol 14 (1991): 1568-70. [PMID: 1721143]
3	Klein RC, Huang SK, Marcus FI, et al "Enhanced antiarrhythmic efficacy of propafenone when used in combination with procainamide or quinidine." Am Heart J 114 (1987): 551-8. [PMID: 3630896]
4	Product Information. Rhythmol (propafenone). Knoll Pharmaceutical Company, Whippany, NJ.
5	Product Information. Rythmol SR (propafenone). GlaxoSmithKline, Research Triangle Park, NC.
6	Zehender M, Hohnloser S, Geibel A, et al "Short-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients." Br Heart J 67 (1992): 491-7. [PMID: 1622701]
7	Canadian Pharmacists Association.
8	Cerner Multum, Inc. "Australian Product Information.".
9	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
10	Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
11	Ace LN, Jaffe JM, Kunka RL "Effect of food and an antacid on quinidine bioavailability." Biopharm Drug Dispos 4 (1983): 183-90. [PMID: 6882885]
12	Min DI, Ku YM, Geraets DR, Lee HC "Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers." J Clin Pharmacol 36 (1996): 469-76. [PMID: 8739026]
13	Product Information. GenESA (arbutamine). Gensia Inc, San Diego, CA.
14	Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5. [PMID: 11103058]
15	Product Information. Trisenox (arsenic trioxide) Cephalon Inc, West Chester, PA.
16	Product Information. Reyataz (atazanavir). Bristol-Myers Squibb, Princeton, NJ.
17	Product Information. Stribild (cobicistat/elvitegravir/emtricitabine/tenofov). Gilead Sciences, Foster City, CA.
18	Harper KM, Knapp DJ, Criswell HE, Breese GR "Vasopressin and alcohol: A multifaceted relationship." Psychopharmacology (Berl) 235 (2018): 3363-79. [PMID: 32936259]
19	Javelot H, El-Hage W, Meyer G, Becker G, Michel B, Hingray C "COVID-19 and (hydroxy)chloroquine-azithromycin combination: should we take the risk for our patients?" Br J Clin Pharmacol Apr 29 (2020): epub ahead of print. [PMID: 32350872]
20	National Institutes of Health (NIH) "Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.".
21	Product Information. Chloroquine Phosphate (chloroquine). West-Ward Pharmaceutical Corporation, Eatontown, NJ.
22	Product Information. Hydroxychloroquine Sulfate (hydroxychloroquine). Prasco Laboratories, Cincinnati, OH.
23	Product Information. Plaquenil (R). (hydroxychloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
24	Roden DM, Harrington RA, Poppas A, Russo AM "Considerations for drug interactions on QTc in exploratory COVID-19 (Coroanvirus disease 2019) treatment." Heart Rhythm Apr 14 (2020): epub ahead of print. [PMID: 32302703]
25	Sacher F, Fauchier L, Boveda S, et.al "Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection." Arch Cardiovasc Dis Apr 24 (2020): epub ahead of print. [PMID: 32354666]
26	Saleh M, Gabriels J, ChangD, et.al "The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection." Circ Arrhythm Electrophysiol Apr 29 (2020): epub ahead of print. [PMID: 32347743]
27	Sapp JL, Alqarawi W, MacIntyre CJ, et.al "Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: A statement from the Canadian Heart Rhythm Society." Can J Cardiol Apr 8 (2020): epub ahead of print. [PMID: 32299753]
28	Smit C, Peeters MYM, van den Anker JN, Knibbe CAJ "Chloroquine for SARS-CoV-2: Implications of its unique pharmacokinetic and safety properties." Clin Pharmacokinet Ar 18 (2020): epub ahead of print. [PMID: 32306288]
29	Bessiere F, Roccia H, Deliniere A, et.al "Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit." JAMA Cardiol May 1 (2020): epub ahead of print. [PMID: 32936266]
30	Borba MGS, Val FFA, Sampaio VS, et.al "Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 1 (SARS-CoV-2) infection: A randomized clinical trial." JAMA Netw Open Apr 1 (2020): epub ahead of print. [PMID: 32330277]
31	Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ "Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)" Mayo Clin Proc Apr 7 (2020): epub ahead of print. [PMID: 32359771]
32	Kapoor A, Pandurangi U, Arora V, et.al "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society." Indian Pacing Electorphysiol J Apr 8 (2020): epub ahead of print. [PMID: 32278018]
33	Mercuro NJ, Yen CF, Shim DJ, et.al "Risk of QT interval prolongation associated with the use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)" JAMA Cardiol May 1:e201834 (2020): epub ahead of print. [PMID: 32936252]
34	mitra RL, Greenstein SA, Epstein lm "An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin Possible benefits of intravenous lidocaine." HeartRythm Case Rep Apr 1 (2020): epub ahead of print. [PMID: 32363145]
35	US Food and Drug Administration "FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF CHLOROQUINE PHOSPHATE SUPPLIED FROM THE STRATEGIC NATIONAL STOCKPILE FOR TREATMENT OF COVID-19 IN CERTAIN HOSPITALIZED PATIENTS. Available from: URL: https://www.fda.gov/media/13653" ([2020, Apr 27]):.
36	US Food and Drug Administration "Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems.".
37	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
38	Product Information. Propulsid (cisapride). Janssen Pharmaceutica, Titusville, NJ.
39	Trinkle R "Comment: syncopal episodes associated with cisapride." Ann Pharmacother 33 (1999): 251. [PMID: 10084425]
40	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
41	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
42	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
43	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
44	Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
45	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
46	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
47	Product Information. Anzemet (dolasetron). Hoechst Marion-Roussel Inc, Kansas City, MO.
48	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
49	Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
50	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
51	Castro VM, Clements CC, Murphy SN, et al. "QT interval and antidepressant use: a cross sectional study of electronic health records." BMJ 346 (2013): f288. [PMID: 23360890]
52	Do A, Noohi S, Elie D, et al. Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry.?Psychosomatics. 2016;57(1):57-63. [PMID: 26633294]
53	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
54	Ansari SR, Chopra N "Gatifloxacin and Prolonged QT Interval." Am J Med Sci 327 (2004): 55-6. [PMID: 14722399]
55	Ball P "Quinolone-induced QT interval prolongation: a not-so-unexpected class effect." J Antimicrob Chemother 45 (2000): 557-9. [PMID: 10797074]
56	Bertino JS Jr, Owens RC Jr, Carnes TD, Iannini PB "Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors." Clin Infect Dis 34 (2002): 861-3. [PMID: 11830802]
57	Dale KM, Lertsburapa K, Kluger J, White CM "Moxifloxacin and torsade de pointes." Ann Pharmacother 41 (2007): 336-40. [PMID: 17284508]
58	Demolis JL, Kubitza D, Tenneze L, Funck-Bretano C "Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects." Clin Pharmacol Ther 68 (2000): 658-66. [PMID: 11180026]
59	Falagas ME, Rafailidis PI, Rosmarakis ES "Arrhythmias associated with fluoroquinolone therapy." Int J Antimicrob Agents 29 (2007): 374-9. [PMID: 17241772]
60	Frothingham R "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy 21 (2001): 1468-72. [PMID: 11765299]
61	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
62	Iannini PB, Circiumaru I "Gatifloxacin-induced QTc prolongation and ventricular tachycardia." Pharmacotherapy 21 (2001): 361-2. [PMID: 11253862]
63	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs." BMJ 322 (2001): 46-7. [PMID: 11141163]
64	Kang J, Wang L, Chen XL, Triggle DJ, Rampe D "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG." Mol Pharmacol 59 (2001): 122-6. [PMID: 11125032]
65	Katritsis D, Camm AJ "Quinolones: cardioprotective or cardiotoxic." Pacing Clin Electrophysiol 26 (2003): 2317-20. [PMID: 14675020]
66	Noel GJ, Natarajan J, Chien S, Hunt TL, Goodman DB, Abels R "Effects of three fluoroquinolones on QT interval in healthy adults after single doses." Clin Pharmacol Ther 73 (2003): 292-303. [PMID: 12709719]
67	Oliphant CM, Green GM "Quinolones: a comprehensive review." Am Fam Physician 65 (2002): 455-64. [PMID: 11858629]
68	Owens RC "QT Prolongation with Antimicrobial Agents : Understanding the Significance." Drugs 64 (2004): 1091-124. [PMID: 15139788]
69	Owens RC "Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes." Pharmacotherapy 21 (2001): 301-19. [PMID: 11253855]
70	Owens RC Jr, Ambrose PG "Torsades de pointes associated with fluoroquinolones." Pharmacotherapy 22 (2002): 663-8 discussion 668-72. [PMID: 12013370]
71	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
72	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
73	Siepmann M, Kirch W "Drug points - Tachycardia associated with moxifloxacin." Br Med J 322 (2001): 23. [PMID: 11141146]
74	Stahlmann R "Clinical toxicological aspects of fluoroquinolones." Toxicol Lett 127 (2002): 269-77. [PMID: 12052667]
75	Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF "Effects of three fluoroquinolones on QT analysis after standard treatment courses." Ann Noninvasive Electrocardiol 11 (2006): 52-6. [PMID: 16472283]
76	White CM, Grant EM, Quintiliani R "Moxifloxacin does increase the corrected QT interval." Clin Infect Dis 33 (2001): 1441-2. [PMID: 11565091]
77	Lode H, Vogel F, Elies W "Grepafloxacin: A review of its safety profile based on clinical trials and postmarketing surveillance." Clin Ther 21 (1999): 61-74. [PMID: 10090425]
78	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
79	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
80	Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I, Yonezawa Y "The association between intravenous haloperidol and prolonged QT interval." J Clin Psychopharmacol 21 (2001): 257-61. [PMID: 11386487]
81	Huyse F, van Schijndel RS "Haloperidol and cardiac arrest." Lancet 2 (1988): 568-9. [PMID: 2900948]
82	Metzger E, Friedman R "Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill." J Clin Psychopharmacol 13 (1993): 128-32. [PMID: 8463445]
83	O'Brien JM, Rockwood RP, Suh KI "Haloperidol-induced torsade de pointes." Ann Pharmacother 33 (1999): 1046-9. [PMID: 10534216]
84	Product Information. Haldol (haloperidol). McNeil Pharmaceutical, Raritan, NJ.
85	Wilt JL, Minnema AM, Johnson RF, Rosenblum AM "Torsade de pointes associated with the use of intravenous haloperidol." Ann Intern Med 119 (1993): 391-4. [PMID: 8338292]
86	Product Information. Serentil (mesoridazine) Boehringer-Ingelheim, Ridgefield, CT.
87	De Bels D, Staroukine M, Devriendt J "Torsades de pointes due to methadone." Ann Intern Med 139 (2003): E156. [PMID: 12859181]
88	Ehret GB, Desmeules JA, Broers B "Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology." Expert Opin Drug Saf 6 (2007): 289-303. [PMID: 17480178]
89	Gil M, Sala M, Anguera I, et al. "QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone." Am J Cardiol 92 (2003): 995-7. [PMID: 14556883]
90	Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS "Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes." Pharmacotherapy 23 (2003): 802-5. [PMID: 12820821]
91	Krantz MJ, Lewkowiez L, Hays H, et al "Torsade de pointes associated with very-high-dose methadone." Ann Intern Med 137 (2002): 501-4. [PMID: 12230351]
92	Krantz MJ, Mehler PS "Synthetic opioids and QT prolongation." Arch Intern Med 163 (2003): 1615 author reply 1615. [PMID: 12860589]
93	Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN "Impact of methadone treatment on cardiac repolarization and conduction in opioid users." Am J Cardiol 95 (2005): 915-8. [PMID: 15781034]
94	Mokwe EO, Ositadinma O "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966000]
95	Sala M, Anguera I, Cervantes M "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966001]
96	Walker PW, Klein D, Kasza L "High dose methadone and ventricular arrhythmias: a report of three cases." Pain 103 (2003): 321-4. [PMID: 12791438]
97	Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
98	Goto M, Sato M, Kitzazawa H, et.al "Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation." Intern Med 53 (2014): 1629-31. [PMID: 25088875]
99	Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y "QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine." Cardiology 84 (1994): 9-13. [PMID: 7511988]
100	Jain A, Jenkins MG "Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine." Cathet Cardiovasc Diagn 18 (1989): 255-7. [PMID: 2605630]
101	Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T "Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve." Cathet Cardiovasc Diagn 19 (1990): 229-36. [PMID: 2334953]
102	Nakayama M, Saito A, Kitazawa H, et.al "Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases." Intern Med 51 (2012): 351-6. [PMID: 22333368]
103	Nakayama M, Tanaka N, Sakoda K, et.al "Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease." Circ J 79 (2015): 530-6. [PMID: 25746536]
104	Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML "Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine." J Am Coll Cardiol 15 (1990): 275-8. [PMID: 2299067]
105	Vrolix M, Piessens J, De Geest H "Torsades de pointes after intracoronary papaverine." Eur Heart J 12 (1991): 273-6. [PMID: 2044564]
106	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
107	Product Information. Barhemsys (amisulpride). Acacia Pharma, Inc, Indianapolis, IN.
108	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
109	Product Information. Orladeyo (berotralstat). BioCryst Pharmaceuticals Inc, Durham, NC.
110	Bailey DG, Dresser GK "Natural products and adverse drug interactions." Can Med Assoc J 170 (2004): 1531-2. [PMID: 15136542]
111	Ho PC, Ghose K, Saville D, Wanwimolruk S "Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers." Eur J Clin Pharmacol 56 (2000): 693-8. [PMID: 11214778]
112	Product Information. Bevyxxa (betrixaban). Portola Pharmaceuticals, South San Francisco, CA.
113	Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
114	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
115	Garrouste C, Philipponnet C, Kaysi S, Enache I, Tiple A, Heng AE "Severe colchicine intoxication in a renal transplant recipient on cyclosporine." Transplant Proc 44 (2012): 2851-2. [PMID: 23146540]
116	Jonsson J, Gelpi JR, Light JA, Aquino A, Maszaros S "Colchicine-induced myoneuropathy in a renal transplant patient." Transplantation 53 (1992): 1369-71. [PMID: 1604496]
117	Kuncl RW, Duncan G, Watson D, et al "Colchicine myopathy and neuropathy." N Engl J Med 316 (1987): 1562-8. [PMID: 3035372]
118	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
119	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
120	Product Information. Cerdelga (eliglustat). Genzyme Corporation, Cambridge, MA.
121	Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
122	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
123	Abernethy DR, Wesche DL, Barbey JT, et al. "Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation." Br J Clin Pharmacol 51 (2001): 231-7. [PMID: 11298069]
124	Giao PT, de Vries PJ "Pharmacokinetic interactions of antimalarial agents." Clin Pharmacokinet 40 (2001): 343-73. [PMID: 11432537]
125	Nosten F, ter Kuile FO, Luxemburger C, et al "Cardiac effects of antimalarial treatment with halofantrine." Lancet 341 (1993): 1054-6. [PMID: 8096959]
126	Product Information. Halfan (halofantrine). GlaxoSmithKline, Philadelphia, PA.
127	Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
128	Sudden death in a traveler following halofantrine administration--Togo, 2000. MMWR Morb Mortal Wkly Rep 50 (2001): 169-70, 179. [PMID: 11393488]
129	Product Information. Exforge HCT (amlodipine/hydrochlorothiazide/valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
130	Mittal SR "Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine." J Assoc Physicians India 62 (2014): 426-7. [PMID: 25438492]
131	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
132	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
133	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
134	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
135	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
136	Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
137	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
138	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
139	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
140	Product Information. Signifor (pasireotide). Novartis Pharmaceuticals, East Hanover, NJ.
141	Product Information. Votrient (pazopanib). GlaxoSmithKline, Research Triangle Park, NC.
142	Tan AR, Gibbon DG, Stein MN, et al. "Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors." Cancer Chemother Pharmacol 71 (2013): 1635-43. [PMID: 23636448]
143	Product Information. Orgovyx (relugolix). Myovant Sciences, Inc., Brisbane, CA.
144	Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
145	Witchel HJ, Hancox JC, Nutt DJ "Psychotropic drugs, cardiac arrhythmia, and sudden death." J Clin Psychopharmacol 23 (2003): 58-77. [PMID: 12544377]
146	Product Information. Fortovase (saquinavir) Roche Laboratories, Nutley, NJ.
147	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
148	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
149	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
150	Demolis JL, Charransol A, Funck-Brentano C, Jaillon P "Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers." Br J Clin Pharmacol 41 (1996): 499-503. [PMID: 8799513]
151	Dupont H, Timsit JF, Souweine B, Gachot B, Wolff M, Regnier B "Torsades de pointe probably related to sparfloxacin." Eur J Clin Microbiol Infect Dis 15 (1996): 350-1. [PMID: 8781892]
152	Jaillon P, Morganroth J, Brumpt I, Talbot G "Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group." J Antimicrob Chemother 37(suppl a) (1996): 161-7. [PMID: 8737135]
153	Lipsky BA, Dorr MB, Magner DJ, Talbot GH "Safety profile of sparfloxacin, a new fluoroquinolone antibiotic." Clin Ther 21 (1999): 148-59. [PMID: 10090432]
154	Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
155	Zix JA, GeerdesFenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
156	Product Information. Vandetanib (vandetanib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
157	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
158	Product Information. Venclexta (venetoclax). AbbVie US LLC, North Chicago, IL.
159	Funck-Brentano C, Kroemer HK, Pavlou H, et al "Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect." Br J Clin Pharmacol 27 (1989): 435-44. [PMID: 2719900]
160	Morike KE, Roden DM "Quinidine-enhanced beta-blockade during treatment with propafenone in extensive metabolizer human subjects." Clin Pharmacol Ther 55 (1994): 28-34. [PMID: 7905369]
161	Siddoway LA, Thompson KA, McAllister CB, Wang T, Wilkinson GR, Roden DM, Woosley RL "Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences." Circulation 75 (1987): 785-91. [PMID: 3829342]
162	Mangum EM, Graham KK "Lopinavir-Ritonavir: a new protease inhibitor." Pharmacotherapy 21 (2001): 1352-63. [PMID: 11714208]
163	Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online.".
164	Product Information. Norvir (ritonavir). Abbott Pharmaceutical, Abbott Park, IL.
165	Amchin J, Ereshefsky L, Zarycranski W, Taylor K, Albano D, Klockowski PM "Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe." J Clin Pharmacol 41 (2001): 443-51. [PMID: 11304901]
166	Aubert RE, Stanek EJ, Yao J, et al "Increased risk of breast cancer recurrence in women initiating tamoxifen with CYP2D6 inhibitors".
167	Bonanni B, Macis D, Maisonneuve P, et al. "Polymorphism in the CYP2D6 tamoxifen-metabolizing gene influences clinical effect but not hot flashes: data from the Italian Tamoxifen Trial." J Clin Oncol 24 (2006): 3708-9. [PMID: 16877740]
168	Borges S, Desta Z, Li L, et al. "Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment." Clin Pharmacol Ther 80 (2006): 61-74. [PMID: 16815318]
169	Borgna JL, Rochefort H "Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues." J Biol Chem 256 (1981): 859-68. [PMID: 7451477]
170	Brauch H, Murdter TE, Eichelbaum M, Schwab M "Pharmacogenomics of tamoxifen therapy." Clin Chem 55 (2009): 1770-82. [PMID: 19574470]
171	Coller JK, Krebsfaenger N, Klein K, et al. "The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver." Br J Clin Pharmacol 54 (2002): 157-167. [PMID: 12207635]
172	Crewe HK, Lennard MS, Tucker GT, Woods FR, Haddock RE "The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes." Br J Clin Pharmacol 34 (1992): 262-5. [PMID: 1389951]
173	Dehal SS, Kupfer D "CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver." Cancer Res 57 (1997): 3402-6. [PMID: 9270005]
174	Desta Z, Flockhart DA "Germline pharmacogenetics of tamoxifen response: have we learned enough?" J Clin Oncol 25 (2007): 5147-9. [PMID: 18024859]
175	Desta Z, Ward BA, Soukhova NV, Flockhart DA "Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6." J Pharmacol Exp Ther (2004):. [PMID: 15159443]
176	Dezentje VO, Guchelaar HJ, Nortier JW, van de Velde CJ, Gelderblom H "Clinical implications of CYP2D6 genotyping in tamoxifen treatment for breast cancer." Clin Cancer Res 15 (2009): 15-21. [PMID: 19118028]
177	Gaston C, Kolesar J "Clinical Significance of CYP2D6 Polymorphisms and Tamoxifen in Women with Breast Cancer." Clin Adv Hematol Oncol 6 (2008): 825-33. [PMID: 19194367]
178	Goetz MP, Kamal A, Ames MM "Tamoxifen Pharmacogenomics: The Role of CYP2D6 as a Predictor of Drug Response." Clin Pharmacol Ther (2007):. [PMID: 17882159]
179	Goetz MP, Loprinzi CL "A hot flash on tamoxifen metabolism." J Natl Cancer Inst 95 (2003): 1734-5. [PMID: 14652227]
180	Goetz MP, Rae JM, Suman VJ, et al. "Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes." J Clin Oncol 23 (2005): 9312-8. [PMID: 16361630]
181	Henry NL, Stearns V, Flockhart DA, Hayes DF, Riba M "Drug interactions and pharmacogenomics in the treatment of breast cancer and depression." Am J Psychiatry 165 (2008): 1251-5. [PMID: 18829880]
182	Jin Y, Desta Z, Stearns V, et al. "CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment." J Natl Cancer Inst 97 (2005): 30-9. [PMID: 15632378]
183	Johnson MD, Zuo H, Lee KH, et al. "Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen." Breast Cancer Res Treat 85 (2004): 151-9. [PMID: 15111773]
184	Jordan VC "Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance." Breast Cancer Res Treat 2 (1982): 123-38. [PMID: 6184101]
185	Jordan VC, Collins MM, Rowsby L, Prestwich G "A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity." J Endocrinol 75 (1977): 305-16. [PMID: 591813]
186	Lash TL, Pedersen L, Cronin-Fenton D, et al "Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram." Br J Cancer 99 (2008): 616-21. [PMID: 20385012]
187	Lehmann D, Nelsen J, Ramanath V, Newman N, Duggan D, Smith A "Lack of attenuation in the antitumor effect of tamoxifen by chronic CYP isoform inhibition." J Clin Pharmacol 44 (2004): 861-5. [PMID: 15286089]
188	Lim HS, Ju Lee H, Seok Lee K, Sook Lee E, Jang IJ, Ro J "Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer." J Clin Oncol 25 (2007): 3837-45. [PMID: 17761971]
189	McCaffrey P "Genetics and drug interactions affect tamoxifen metabolism." Lancet Oncol 6 (2005): 72. [PMID: 15704296]
190	Ponzone R, Biglia N, Sismondi P "Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine." J Natl Cancer Inst 96 (2004): 883-4 author reply 884-5. [PMID: 15173274]
191	Rochat B "Role of cytochrome p450 activity in the fate of anticancer agents and in drug resistance : focus on tamoxifen, Paclitaxel and imatinib metabolism." Clin Pharmacokinet 44 (2005): 349-66. [PMID: 15828850]
192	Schroth W, Antoniadou L, Fritz P, et al. "Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes." J Clin Oncol 25 (2007): 5187-93. [PMID: 18024866]
193	Stearns V, Johnson MD, Rae JM, et al. "Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine." J Natl Cancer Inst 95 (2003): 1758-64. [PMID: 14652237]
194	Wegman P, Elingarami S, Carstensen J, Stal O, Nordenskjold B, Wingren S "Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer." Breast Cancer Res 9 (2007): R7. [PMID: 17244352]
195	Wegman P, Vainikka L, Stal O, et al "Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients." Breast Cancer Res 7 (2005): R284-90. [PMID: 15987423]
196	Young D "Genetics examined in tamoxifen's effectiveness: recurrence warning urged for labeling." Am J Health Syst Pharm 63 (2006): 2286, 2296. [PMID: 17105997]
197	Crewe HK, Notley LM, Wunsch RM, Lennard MS, Gillam EM "Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen." Drug Metab Dispos 30 (2002): 869-74. [PMID: 12124303]
198	Ratliff B, Dietze EC, Bean GR, Moore C, Wanko S, Seewaldt VL "Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine." J Natl Cancer Inst 96 (2004): 883 author reply 884-5. [PMID: 15173275]
199	Fletcher GF, Kazamias TM "Cardiotoxic effects of Mellaril: conduction disturbances and supraventricular arrhythmias." Am Heart J 78 (1969): 135-8. [PMID: 5794785]
200	Hartigan-Go K, Bateman DN, Nyberg G, Martensson E, Thomas SHL "Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans." Clin Pharmacol Ther 60 (1996): 543-53. [PMID: 8941027]
201	Liberatore MA, Robinson DS "Torsade de pointes: a mechanism for sudden death associated with neuroleptic drug therapy?" J Clin Psychopharmacol 4 (1984): 143-6. [PMID: 6145728]
202	Product Information. Mellaril (thioridazine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
203	Granfors MT, Backman JT, Laitila J, Neuvonen PJ "Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitro." Br J Clin Pharmacol 57 (2004): 349-53. [PMID: 14998432]
204	Granfors MT, Backman JT, Neuvonen M, Ahonen J, Neuvonen PJ "Fluvoxamine drastically increases concentrations and effects of tizanidine: A potentially hazardous interaction." Clin Pharmacol Ther 75 (2004): 331-41. [PMID: 15060511]
205	Granfors MT, Backman JT, Neuvonen M, Neuvonen PJ "Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism." Clin Pharmacol Ther 76 (2004): 598-606. [PMID: 15592331]
206	Momo K, Doki K, Hosono H, Homma M, Kohda Y "Drug interaction of tizanidine and fluvoxamine." Clin Pharmacol Ther 76 (2004): 509-10. [PMID: 15536467]
207	Momo K, Homma M, Kohda Y, Ohkoshi N, Yoshizawa T, Tamaoka A "Drug interaction of tizanidine and ciprofloxacin: Case report." Clin Pharmacol Ther 80 (2006): 717-9. [PMID: 17178273]
208	Product Information. Vioxx (rofecoxib). Merck & Co, Inc, West Point, PA.
209	Product Information. Zanaflex (tizanidine). Acorda Therapeutics, Hawthorne, NY.
210	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
211	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
212	Product Information. Eligard (leuprolide). Sanofi Winthrop Pharmaceuticals, New York, NY.
213	Product Information. Firmagon (degarelix). Ferring Pharmaceuticals Inc, Tarrytown, NY.
214	Product Information. Lupron (leuprolide). TAP Pharmaceuticals Inc, Deerfield, IL.
215	Product Information. Plenaxis (abarelix). Praecis Pharmaceuticals Inc, Waltham, MA.
216	Product Information. Trelstar (triptorelin) Pharmacia and Upjohn, Kalamazoo, MI.
217	Product Information. Vantas (histrelin). Endo Pharmaceuticals (formally Indevus Pharmaceuticals Inc), Lexington, MA.
218	Product Information. Zoladex (goserelin). Zeneca Pharmaceuticals, Wilmington, DE.
219	Product Information. Actemra (tocilizumab). Genentech, South San Francisco, CA.
220	Product Information. Amevive (alefacept). Biogen, Cambridge, MA.
221	Product Information. Arcalyst (rilonacept). Regeneron Pharmaceuticals Inc, Tarrytown, NY.
222	Product Information. Cosentyx (secukinumab). Novartis Pharmaceuticals, East Hanover, NJ.
223	Product Information. Gamifant (emapalumab). Sobi Inc, Ardmore, PA.
224	Product Information. Ilaris (canakinumab). Novartis Pharmaceuticals, East Hanover, NJ.
225	Product Information. Ilumya (tildrakizumab). Merck & Company Inc, Whitehouse Station, NJ.
226	Product Information. Kevzara (sarilumab). sanofi-aventis, Bridgewater, NJ.
227	Product Information. Remicade (infliximab). Centocor Inc, Malvern, PA.
228	Product Information. Simponi (golimumab). Centocor Inc, Malvern, PA.
229	Product Information. Skyrizi (risankizumab). AbbVie US LLC, North Chicago, IL.
230	Product Information. Stelara (ustekinumab). Centocor Inc, Malvern, PA.
231	Product Information. Sylvant (siltuximab). Janssen Biotech, Inc., Horsham, PA, PA.
232	Product Information. Taltz Autoinjector (ixekizumab). Eli Lilly and Company, Indianapolis, IN.
233	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
234	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
235	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
236	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
237	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
238	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
239	Product Information. Uroxatral (alfuzosin). sanofi-aventis , Bridgewater, NJ.
240	Product Information. Lotronex (alosetron). Glaxo Wellcome, Research Triangle Park, NC.
241	Katz MR "Raised serum levels of desipramine with the antiarrhythmic propafenone ." J Clin Psychiatry 52 (1991): 432-3. [PMID: 1938981]
242	Product Information. Sinequan (doxepin). Roerig Division, New York, NY.
243	Botsch S, Gautier JC, Beaune P, Eichelbaum M, Kroemer HK "Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites." Mol Pharmacol 43 (1993): 120-6. [PMID: 8423765]
244	Kates RE, Yee YG, Kirsten EB "Interaction between warfarin and propafenone in healthy volunteer subjects." Clin Pharmacol Ther 42 (1987): 305-11. [PMID: 3621785]
245	Thijssen HH, Flin ois JP, Beaune PH "Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes." Drug Metab Dispos 28 (2000): 1284-90. [PMID: 11038154]
246	Wells PS, Holbrook AM, Crowther NR, Hirsh J "Interactions of warfarin with drugs and food." Ann Intern Med 121 (1994): 676-83. [PMID: 7944078]
247	Product Information. Apokyn (apomorphine). Mylan Pharmaceuticals Inc, Morgantown, WV.
248	Dufresne RL, Weber SS, Becker RE "Bupropion hydrochloride." Drug Intell Clin Pharm 18 (1984): 957-64. [PMID: 6439541]
249	Enns MW "Seizure during combination of trimipramine and bupropion." J Clin Psychiatry 62 (2001): 476-7. [PMID: 11465529]
250	Guzey C, Norstrom A, Spigset O "Change from the CYP2D6 extensive metabolizer to the poor metabolizer phenotype during treatment with bupropion." Ther Drug Monit 24 (2002): 436-7. [PMID: 12021638]
251	James WA, Lippmann S "Bupropion: overview and prescribing guidelines in depression." South Med J 84 (1991): 222-4. [PMID: 1899294]
252	Product Information. Aplenzin (buPROPion). sanofi-aventis , Bridgewater, NJ.
253	Product Information. Wellbutrin (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
254	Product Information. Wellbutrin SR (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
255	Product Information. Wellbutrin XL (buPROPion). GlaxoSmithKline, Philadelphia, PA.
256	Product Information. Zyban (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
257	Shad MU "A possible bupropion and imipramine interaction." J Clin Psychopharmacol 17 (1997): 118. [PMID: 10950476]
258	Shin YW, Erm TM, Choi EJ, Kim SY "A Case of Prolonged Seizure Activity After Combined Use of Bupropion and Clomipramine." Clin Neuropharmacol 27 (2004): 192-194. [PMID: 15319707]
259	Ahmad S "Metoprolol-induced delirium perpetuated by propafenone." Am Fam Physician 44 (1991): 1142,4. [PMID: 1927831]
260	Amemiya M, Tabei K, Furuya H, Sakairi Y, Asano Y "Pharmacokinetics of carteolol in patients with impaired renal function." Eur J Clin Pharmacol 43 (1992): 417-21. [PMID: 1451723]
261	Barbey JT "Clinical pharmacology and beta-blocking efficacy of propafenone." J Cardiovasc Pharmacol 17 (1991): s41-3. [PMID: 1723117]
262	Hardman JG, Gilman AG, Limbird LE eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 9th ed." New York, NY: McGraw-Hill (1995):.
263	Janku I, Perlik F, Tkaczykova M, Brodanova M "Disposition kinetics and concentration-effect relationship of metipranolol in patients with cirrhosis and healthy subjects." Eur J Clin Pharmacol 42 (1992): 337-40. [PMID: 1349528]
264	Kowey PR, Kirsten EB, Fu CJ, Mason WD "Interaction between propranolol and propafenone in healthy volunteers." J Clin Pharmacol 29 (1989): 512-7. [PMID: 2754020]
265	Le Coz F, Sauleman P, Poirier JM, Cuche JL, Midavaine M, Rames A, Lecocq B, Jaillon P "Oral pharmacokinetics of bisoprolol in resting and exercising healthy volunteers." J Cardiovasc Pharmacol 18 (1991): 28-34. [PMID: 1719288]
266	McGourty JC, Silas JH, Fleming JJ, McBurney A, Ward JW "Pharmacokinetics and beta-blocking effects of timolol in poor and extensive metabolizers of debrisoquin." Clin Pharmacol Ther 38 (1985): 409-13. [PMID: 2864157]
267	McTavish D, Campoli-Richards D, Sorkin EM "Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy." Drugs 45 (1993): 232-58. [PMID: 7681374]
268	Morgan T "Clinical pharmacokinetics and pharmacodynamics of carvedilol." Clin Pharmacokinet 26 (1994): 335-46. [PMID: 7914479]
269	Piquette-Miller M, Foster RT, Kappagoda CT, Jamali F "Effect of aging on the pharmacokinetics of acebutolol enantiomers." J Clin Pharmacol 32 (1992): 148-56. [PMID: 1613125]
270	Product Information. Betapace (sotalol). Berlex, Richmond, CA.
271	Product Information. Blocadren (timolol). Merck & Co, Inc, West Point, PA.
272	Product Information. Brevibloc (esmolol). DuPont Pharmaceuticals, Wilmington, DE.
273	Product Information. Cartrol (carteolol). Abbott Pharmaceutical, Abbott Park, IL.
274	Product Information. Corgard (nadolol). Bristol-Myers Squibb, Princeton, NJ.
275	Product Information. Inderal (propranolol). Wyeth-Ayerst Laboratories, Philadelphia, PA.
276	Product Information. Levatol (penbutolol). Reed and Carnrick, Jersey City, NJ.
277	Product Information. Normodyne (labetalol). Schering Laboratories, Kenilworth, NJ.
278	Product Information. Tenormin (atenolol). ICN Pharmaceuticals Inc, Cost Mesa, CA.
279	Desmedt S, Spinewine A, Jadoul M, Henrard S, Wouters D, Dalleur O. Impact of a clinical decision support system for drug dosage in patients with renal failure.?Int J Clin Pharm. 2018;40(5):1225-1233. [PMID: 29785684]
280	Smith RL "Polymorphic metabolism of the beta-adrenoreceptor blocking drugs and its clinical relevance." Eur J Clin Pharmacol 28 (1985): 77-84. [PMID: 2865154]
281	Stagni G, Davis PJ, Ludden TM "Human pharmacokinetics of betaxolol enantiomers." J Pharm Sci 80 (1991): 321-4. [PMID: 1865331]
282	Wagner F, Kalusche D, Trenk D, et al "Drug interaction between propafenone and metoprolol." Br J Clin Pharmacol 24 (1987): 213-20. [PMID: 3620296]
283	Wagner F, Kalusche D, Trenk D, Jahnchen E, Roskamm H "Drug interaction between propafenone and metoprolol." Br J Clin Pharmacol 24 (1987): 213-20. [PMID: 3620296]
284	Product Information. Celebrex (celecoxib). Searle, Chicago, IL.
285	Product Information. Evoxac (cevimeline) Daiichi Pharmaceuticals, Fort lee, NJ.
286	Pritchett EL, Smith WM, Kirsten EB "Pharmacokinetic and pharmacodynamic interactions of propafenone and cimetidine." J Clin Pharmacol 28 (1988): 619-24. [PMID: 3063727]
287	Product Information. Sensipar (cinacalcet). Amgen USA, Thousand Oaks, CA.
288	Product Information. Onfi (clobazam). Lundbeck Inc, Deerfield, IL.
289	Walzer M, Bekersky I, Blum RA, Tolbert D "Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes." Pharmacotherapy 32 (2012): 340-53. [PMID: 22422635]
290	Product Information. Lamprene (clofazimine). Novartis Pharmaceuticals, East Hanover, NJ.
291	Caraco Y, Sheller J, Wood AJJ "Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamic effects." J Pharmacol Exp Ther 290 (1999): 413-22. [PMID: 10381807]
292	Caraco Y, Sheller J, Wood JJ "Pharmacogenetic determination of the effects of codeine and prediction of drug interactions." J Pharmacol Exp Ther 278 (1996): 1165-74. [PMID: 8819499]
293	Desmeules J, Dayer P, Gascon MP, Magistris M "Impact of genetic and environmental factors on codeine analgesia." Clin Pharmacol Ther 45 (1989): 122. [PMID: 1782973]
294	Desmeules J, Gascon MP, Dayer P, Magistris M "Impact of environmental and genetic factors on codeine analgesia." Eur J Clin Pharmacol 41 (1991): 23-6. [PMID: 1782973]
295	Hersh EV, Moore PA "Drug interactions in dentistry: the importance of knowing your CYPs." J Am Dent Assoc 135 (2004): 298-311. [PMID: 15058617]
296	Poulsen L, Brosen K, Srendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH "Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects." Eur J Clin Pharmacol 51 (1996): 289-95. [PMID: 9010701]
297	Sindrup SH, Arendt-Nielsen L, Brosen K, et al "The effect of quinidine on the analgesic effect of codeine." Eur J Clin Pharmacol 42 (1992): 587-92. [PMID: 1623898]
298	Sindrup SH, Brosen K, Bjerring P, et al. "Codeine increases pain threshold to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine." Clin Pharmacol Ther 49 (1991): 686-93. [PMID: 2249379]
299	Sindrup SH, Hofmann U, Asmussen J, Mikus G, Brosen K, Nielsen F, Ingwersen SH, Broen Christensen C "Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake." Eur J Clin Pharmacol 49 (1996): 503-9. [PMID: 8706777]
300	Thorn CF, Klein TE, Altman RB "Codeine and morphine pathway." Pharmacogenet Genomics 19 (2009): 556-8. [PMID: 19512957]
301	Vevelstad M, Pettersen S, Tallaksen C, Brors O "O-demethylation of codeine to morphine inhibited by low-dose levomepromazine." Eur J Clin Pharmacol 65 (2009): 795-801. [PMID: 19308365]
302	Zhou SF "Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II." Clin Pharmacokinet 48 (2009): 761-804. [PMID: 19902987]
303	Product Information. Welchol (colesevelam) Daiichi Sankyo, Inc., Parsippany, NJ.
304	Product Information. Enablex (darifenacin). Novartis Pharmaceuticals, East Hanover, NJ.
305	Multum Information Services, Inc. Expert Review Panel.
306	Product Information. Cerubidine (daunorubicin). Wyeth-Ayerst Laboratories, Philadelphia, PA.
307	Product Information. Daunoxome (daunorubicin liposomal). Nexstar Pharmaceuticals Inc, Boulder, CO.
308	Product Information. Idamycin (idarubicin). Pharmacia and Upjohn, Kalamazoo, MI.
309	Funck-Brentano C, Jacqz-Aigrain E, Leenhardt A, Roux A, Poirier JM, Jaillon P "Influence of amiodarone on genetically determined drug metabolism in humans." Clin Pharmacol Ther 50 (1991): 259-66. [PMID: 1914360]
310	Product Information. Qelbree (viloxazine). Supernus Pharmaceuticals Inc, Rockville, MD.
311	Product Information. Zytiga (abiraterone). Centocor Inc, Malvern, PA.
312	Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
313	Skinner MH, Kuan HY, Pan A, et al. "Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers." Clin Pharmacol Ther 73 (2003): 170-7. [PMID: 12621382]
314	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
315	Alfaro CL, Lam YWF, Simpson J, Ereshefsky L "CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline." J Clin Psychopharmacol 19 (1999): 155-63. [PMID: 10211917]
316	Cai WM, Chen B, Zhou Y, Zhang YD "Fluoxetine impairs the CYP2D6-mediated metabolism of propafenone enantiomers in healthy Chinese volunteers." Clin Pharmacol Ther 66 (1999): 516-21. [PMID: 10579479]
317	Hemeryck A, DeVriendt C, Belpaire FM "Effect of selective serotonin reuptake inhibitors on the oxidative metabolism of propafenone: In vitro studies using human liver microsomes." J Clin Psychopharmacol 20 (2000): 428-34. [PMID: 10917404]
318	Product Information. Paxil (paroxetine). GlaxoSmithKline, Research Triangle Park, NC.
319	Product Information. Prozac (fluoxetine). Dista Products Company, Indianapolis, IN.
320	Product Information. Zoloft (sertraline). Roerig Division, New York, NY.
321	Product Information. Reminyl (galantamine) Janssen Pharmaceuticals, Titusville, NJ.
322	Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
323	Product Information. Gleevec (imatinib mesylate). Novartis Pharmaceuticals, East Hanover, NJ.
324	Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32. [PMID: 7042176]
325	Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75. [PMID: 9186877]
326	Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9. [PMID: 2178522]
327	Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33. [PMID: 7885977]
328	Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24. [PMID: 12796155]
329	Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6. [PMID: 3168573]
330	Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6. [PMID: 7446635]
331	Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9. [PMID: 708661]
332	Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5. [PMID: 7197475]
333	Hypokalaemia due to salbutamol overdosage. Br Med J (Clin Res Ed) 283 (1981): 500-1. [PMID: 6114774]
334	Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20. [PMID: 3956296]
335	Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51. [PMID: 11410561]
336	Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90. [PMID: 16750469]
337	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
338	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
339	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
340	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
341	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
342	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
343	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
344	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
345	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.
346	Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7. [PMID: 9583400]
347	Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9. [PMID: 19514]
348	Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5. [PMID: 9581741]
349	Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9. [PMID: 7988180]
350	Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71. [PMID: 3545273]
351	Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61. [PMID: 1972557]
352	Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9. [PMID: 1978872]
353	Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9. [PMID: 921062]
354	Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
355	Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
356	Schaefer DC, Cheskin LJ "Constipation in the elderly." Am Fam Physician 58 (1998): 907-14. [PMID: 9767726]
357	Product Information. Chirocaine (levobupivacaine) Organon, West Orange, NJ.
358	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs. Prolongation of QT interval is probably a class effect of fluoroquinolones." Br Med J 322 (2001): 46-7. [PMID: 11141163]
359	Kahn JB "Latest industry information on the safety profile of levofloxacin in the US." Chemotherapy 47 Suppl 3 (2001): 32-7. [PMID: 11549787]
360	Makaryus AN, Byrns K, Makaryus MN, Natarajan U, Singer C, Goldner B "Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?" South Med J 99 (2006): 52-6. [PMID: 16466123]
361	Nykamp DL, Blackmon CL, Schmidt PE, Roberson AG "QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine." Ann Pharmacother 39 (2005): 543-6. [PMID: 15687478]
362	Product Information. Floxin (ofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
363	Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
364	Samaha FF "QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin." Am J Med 107 (1999): 528-9. [PMID: 10569314]
365	Eggleston W, Clark KH, Marraffa JM "Loperamide abuse associated with cardiac dysrhythmia and death." Ann Emerg Med 69 (2017): 83-6. [PMID: 27140747]
366	US Food and Drug Administration "FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse.".
367	Canadian Pharmacists Association "e-CPS."
368	Product Information. Remeron (mirtazapine). Organon, West Orange, NJ.
369	Product Information. Sandostatin (octreotide). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
370	Product Information. Somatuline Depot (lanreotide). Ipsen Inc, Milford, MA.
371	Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.
372	Product Information. Definity (perflutren). Lantheus Medical Imaging Inc, North Billerica, MA.
373	Product Information. Optison (perflutren). Mallinckrodt Medical Inc, St. Louis, MO.
374	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
375	Product Information. Kaletra (lopinavir-ritonavir) Abbott Pharmaceutical, Abbott Park, IL.
376	Product Information. Alecensa (alectinib). Genentech, South San Francisco, CA.
377	Product Information. Tekturna (aliskiren). Novartis Pharmaceuticals, East Hanover, NJ.
378	Tapaninen T, Backman JT, Kurkinen K, Neuvonen P, Niemi M "Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren." J Clin Pharmacol 51 (2011): 359-67. [PMID: 20400651]
379	Product Information. Eliquis (apixaban). Bristol-Myers Squibb Canada Inc, Montreal, IN.
380	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
381	Kane JM, Carson WH, Saha AR, et al. "Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder." J Clin Psychiatry 63 (2002): 763-71. [PMID: 12363115]
382	Keck PE Jr, Marcus R, Tourkodimitris S, et al. "A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania." Am J Psychiatry 160 (2003): 1651-8. [PMID: 12944341]
383	Nelson S, Leung JG "Torsades de Pointes After Administration of Low-Dose Aripiprazole (February)." Ann Pharmacother (2013):. [PMID: 23362038]
384	Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG "Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study." J Clin Psychiatry 64 (2003): 1048-56. [PMID: 14628980]
385	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
386	Product Information. Saphris (asenapine). Schering-Plough Corporation, Kenilworth, NJ.
387	Product Information. Treanda (bendamustine). Cephalon Inc, West Chester, PA.
388	Product Information. Mektovi (binimetinib). Array BioPharma Inc., Boulder, CO.
389	Abbas R, Hug BA, Leister C, Sonnichsen D "A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects." Int J Cancer 131 (2012): Epub. [PMID: 22065400]
390	Product Information. Vizimpro (dacomitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
391	Product Information. Zokinvy (lonafarnib). Eiger BioPharmaceuticals, Palo Alto, CA.
392	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
393	Product Information. Austedo (deutetrabenazine). Teva Pharmaceuticals USA, North Wales, PA.
394	Gorski JC, Huang SM, Pinto A, et al. "The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo." Clin Pharmacol Ther 75 (2004): 89-100. [PMID: 14749695]
395	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
396	Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
397	Product Information. Halaven (eribulin). Eisai Inc, Teaneck, NJ.
398	Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
399	Product Information. Afinitor (everolimus). Novartis Pharmaceuticals, East Hanover, NJ.
400	Product Information. Toviaz (fesoterodine). Pfizer U.S. Pharmaceuticals Group, New York, NY.
401	Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
402	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
403	Product Information. Givlaari (givosiran). Alnylam Pharmaceuticals, Cambridge, MA.
404	Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
405	Product Information. Ravicti (glycerol phenylbutyrate). Hyperion Therapeutics Inc, South San Francisco, CA.
406	Product Information. Besponsa (inotuzumab ozogamicin). Wyeth Laboratories, Philadelphia, PA.
407	Product Information. Vimpat (lacosamide). UCB Pharma Inc, Smyrna, GA.
408	Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
409	Product Information. Lucemyra (lofexidine). US WorldMeds LLC, Louisville , KY.
410	Product Information. Belviq (lorcaserin). Eisai Inc, Teaneck, NJ.
411	Product Information. Myrbetriq (mirabegron). Astellas Pharma US, Inc, Deerfield, IL.
412	Product Information. Isturisa (osilodrostat). Recordati Rare Diseases Inc, Lebanon, NJ.
413	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
414	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
415	Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
416	Product Information. Seroquel (quetiapine). Zeneca Pharmaceuticals, Wilmington, DE.
417	Sala M, Vicentini A, Brambilla P, et al. "QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy." Ann Gen Psychiatry 4 (2005): 1. [PMID: 15845138]
418	Vieweg WV "New generation antipsychotic drugs and QTc interval prolongation." Prim Care Companion J Clin Psychiatry 5 (2003): 205-15. [PMID: 15213787]
419	Vieweg WV, Schneider RK, Wood MA "Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine." Acta Psychiatr Scand 112 (2005): 318-22. [PMID: 16156840]
420	Product Information. Azilect (rasagiline). Teva Pharmaceuticals USA, North Wales, PA.
421	Product Information. Priftin (rifapentine). Hoechst Marion-Roussel Inc, Kansas City, MO.
422	Product Information. Nurtec ODT (rimegepant). Biohaven Pharmaceuticals, New Haven, CT.
423	Product Information. Qinlock (ripretinib). Deciphera Pharmaceuticals, Waltham, MA.
424	Product Information. Daliresp (roflumilast). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
425	Product Information. Daxas (roflumilast). Nycomed Inc, Princeton, NJ.
426	Product Information. Ultane (sevoflurane). Abbott Pharmaceutical, Abbott Park, IL.
427	Product Information. Olysio (simeprevir). Janssen Pharmaceuticals, Titusville, NJ.
428	Product Information. Sutent (sunitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
429	Product Information. Talzenna (talazoparib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
430	Product Information. Hetlioz (tasimelteon). Vanda Pharmaceuticals Inc, Rockville, MD.
431	Product Information. Xenazine (tetrabenazine). Prestwick Pharmaceuticals Inc, Washington DC, VA.
432	Product Information. Samsca (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
433	Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
434	Product Information. Ingrezza (valbenazine). Neurocrine Biosciences, Inc., San Diego, CA.
435	Hanci V, Aydin M, Yurtlu BS, et.al "Anesthesia induction with sevoflurane and propofol: evaluation of P-wave dispersion, QT and corrected QT intervals." Kaohsiung J Med Sci 26 (2010): 470-7. [PMID: 20837343]
436	Kim DH, Kweon TD, Nam SB, Han DW, Cho WY, Lee JS "Effects of target concentration infusion of propofol and tracheal intubation on QTc interval." Anaesthesia 63 (2008): 1061-4. [PMID: 18717665]
437	Kleinsasser A, Kuenszberg E, Loeckinger A, et.al "Sevoflurane, but not propofol, significantly prolongs the Q-T interval." Anesth Analg 90 (2000): 25-7. [PMID: 10624970]
438	Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F "Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol." Anaesthesia 56 (2001): 248-50. [PMID: 11251432]
439	Paventi S, Santevecchi A, Ranieri R "Effects of sevoflurane versus propofol on QT interval." Minerva Anestesiol 67 (2001): 637-40. [PMID: 11731753]
440	Scalese MJ, Herring HR, Rathburn RC, Skrepnek GH, Ripley TL "Propofol-associated QTc prolongation." Ther Adv Drug Saf 7 (2016): 68-78. [PMID: 27298717]
441	Staikou C, Stamelos M, Stavroulakis E "Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity." Br J Anaesth 112 (2014): 217-30. [PMID: 24305646]
442	Toyoda T, Terao Y, Oji M, Okada M, Fukusaki M, Sumikawa K "The interaction of antiemetic dose of droperidol with propofol on QT interval during anesthetic induction." J Anesth 27 (2013): 885-9. [PMID: 23660990]
443	Whyte SD, Booker PD, Buckley DG "The Effects of Propofol and Sevoflurane on the QT Interval and Transmural Dispersion of Repolarization in Children." Anesth Analg 100 (2005): 71-77. [PMID: 15616054]
444	Wutzler A, De Asmundis C, Matsuda H, et.al "Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults." J Electrocardiol 51 (2018): 170-4. [PMID: 29174097]
445	Product Information. Rozerem (ramelteon). Takeda Pharmaceuticals America, Lincolnshire, IL.
446	European Medicines Agency "CHMP Assessment Report for Latixa. International nonproprietary name: ranolazine.".
447	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
448	Borcherding SM, Baciewicz AM, Self TH "Update on rifampin drug interactions." Arch Intern Med 152 (1992): 711-6. [PMID: 1558427]
449	Castel JM, Cappiello E, Leopaldi D, Latini R "Rifampicin lowers plasma concentrations of propafenone and its antiarrhythmic effect." Br J Clin Pharmacol 30 (1990): 155-6. [PMID: 2390428]
450	Venkatesan K "Pharmacokinetic drug interactions with rifampicin." Clin Pharmacokinet 22 (1992): 47-65. [PMID: 1559307]
451	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
452	Product Information. Exelon (rivastigmine) Novartis Pharmaceuticals, East Hanover, NJ.
453	Product Information. Razadyne (galantamine). Johnson and Johnson Medical Inc, Arlington, TX.
454	Product Information. Noroxin (norfloxacin). Merck & Co, Inc, West Point, PA.
455	Product Information. Requip (ropinirole). SmithKline Beecham, Philadelphia, PA.
456	Product Information. Nexavar (sorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
457	Franco-Salinas G, de la Rosette JJ, Michel MC "Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations." Clin Pharmacokinet 49 (2010): 177-88. [PMID: 20170206]
458	Kamimura H, Oishi S, Matsushima H, et al. "Identification of cytochrome P450 isozymes involved in metabolism of the alpha1-adrenoceptor blocker tamsulosin in human liver microsomes." Xenobiotica 28 (1998): 909-22. [PMID: 9849639]
459	Product Information. Flomax (tamsulosin). Boehringer-Ingelheim, Ridgefield, CT.
460	Demolis JL, Vacheron F, Cardus S, Funck-Brentano C "Effect of single and repeated oral doses of telithromycin on cardiac QT interval in healthy subjects." Clin Pharmacol Ther 73 (2003): 242-52. [PMID: 12621389]
461	Product Information. Ketek (telithromycin). Aventis Pharmaceuticals, Bridgewater, NJ.
462	European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products "European Public Assessment Report Ketek (telithromycin) (Rev. 2) ".
463	AbdelRahman SM, Gotschall RR, Kauffman RE, Leeder JS, Kearns GL "Investigation of terbinafine as a CYP2D6 inhibitor in vivo." Clin Pharmacol Ther 65 (1999): 465-72. [PMID: 10340911]
464	Gupta AK, Katz HI, Shear NH "Terbinafine and potential drug interactions - Reply." J Am Acad Dermatol 43 (2000): 883-4. [PMID: 11050604]
465	Product Information. Lamisil (terbinafine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
466	Van der Kuy PH, Hooymans PM, Verkaaik AJ "Nortriptyline intoxication induced by terbinafine." BMJ 316 (1998): 441. [PMID: 9492672]
467	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
468	Edeki TI, He HB, Wood AJJ "Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops: potential for oral-ophthalmic drug interaction." JAMA 274 (1995): 1611-3. [PMID: 7474246]
469	Fraunfelder FT, Fraunfelder FW Randall JA "Drug-Induced Ocular Side Effects 5th" Boston, MA: Butterworth-Heinemann (2001):.
470	Lewis RV, Lennard MS, Jackson PR, Tucker GT, Ramsay LE, Woods HF "Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics." Br J Clin Pharmacol 19 (1985): 329-33. [PMID: 2859048]
471	Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5. [PMID: 15792261]
472	Dattilo PB, Nordin C "Prolonged QT associated with an overdose of trazodone." J Clin Psychiatry 68 (2007): 1309-10. [PMID: 17854263]
473	Levenson JL "Prolonged QT interval after trazodone overdose." Am J Psychiatry 156 (1999): 969-70. [PMID: 10360146]
474	Mazur A, Strasberg B, Kusniec J, Sclarovsky S "QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination." Int J Cardiol 52 (1995): 27-9. [PMID: 8707432]
475	Product Information. Oleptro (traZODone). Labopharm Inc, Laval, AL.
476	Sams RA, Muir WW. Effects of phenobarbital on thiopental pharmacokinetics in greyhounds. Am J Vet Res. 1988;49(2):245-249. [PMID: 3348533]
477	Rojas-Fernandez C, Fisher C "Drug interactions and donepezil." J Am Geriat Soc 40 (2000): 597-8. [PMID: 10811561]
478	Tiseo PJ, Perdomo CA, Friedhoff LT "Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses." Br J Clin Pharmacol 46 (1998): 30-4. [PMID: 9839763]
479	Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F "QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone." Pacing Clin Electrophysiol 28 (2005): 472-3. [PMID: 15869686]
480	Product Information. Flagyl (metronidazole). Searle, Skokie, IL.
481	Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN). Aptalis Pharma, Birmingham, AL.
482	Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
483	Product Information. Dificid (fidaxomicin). Optimer Pharmaceuticals, San Diego, CA.
484	Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]
485	Darpo B "Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes." Eur Heart J Suppl 3(Suppl K) (2001): K70-80.
486	Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T "QT prolongation and torsades de pointes after administration of trimethoprin-sulfamethoxazole." Am J Cardiol 59 (1987): 376-7. [PMID: 3492908]
487	Wiener I, Rubin D, Martinez E, et al "QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration." Mt Sinai J Med 48 (1981): 53-5. [PMID: 6970886]
488	Brynne N, Svanstrom C, AbergWistedt A, Hallen B, Bertilsson L "Fluoxetine inhibits the metabolism of tolterodin-pharmacokinetic implications and proposed clinical relevance." Br J Clin Pharmacol 48 (1999): 553-63. [PMID: 10583026]
489	Product Information. Detrol (tolterodine). Pharmacia and Upjohn, Kalamazoo, MI.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence